English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
MARKETS

Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & Drugs

| BSE 2397.70 -36.75 (-1.51%) | |

BSE Live

Oct 13, 12:53
2397.70 -36.75 (-1.51%)
Volume
AVERAGE VOLUME
5-Day
3,695
10-Day
3,141
30-Day
2,557
1,334

  • Prev. Close

    2434.45

  • Open Price

    2412.20

  • Bid Price (Qty.)

    2397.70 (8)

  • Offer Price (Qty.)

    2401.20 (8)

NSE Live

Oct 13, 12:53
2399.20 -35.00 (-1.44%)
Volume
AVERAGE VOLUME
5-Day
157,594
10-Day
150,459
30-Day
121,505
26,611

  • Prev. Close

    2434.20

  • Open Price

    2429.80

  • Bid Price (Qty.)

    2399.30 (1)

  • Offer Price (Qty.)

    2399.80 (38)

Financials

Cash Flow of Ajanta Pharma (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,180.06 1,096.95 699.85 900.54 902.09  
Net CashFlow From Operating Activities 1,053.80 735.35 736.29 542.34 466.99  
Net Cash Used In Investing Activities -349.60 105.02 -501.31 -66.04 -162.68  
Net Cash Used From Financing Activities -715.71 -1,047.70 -105.12 -457.30 -268.90  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -11.51 -207.33 129.86 19.00 35.41  
Cash And Cash Equivalents Begin of Year 61.78 268.85 139.83 119.88 84.95  
Cash And Cash Equivalents End Of Year 50.27 61.52 269.69 138.88 120.36  
Source : Dion Global Solutions Limited

Results of Ajanta Pharma

  • 01.01.1970

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Ajanta Pharma Stock Price | Ajanta Pharma Stock Quote | Ajanta Pharma Results | Ajanta Pharma News | View All Related Searches
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347